Brief: Medivir Resolves On Rights Issue Of About SEK 170 Mln

Medivir AB

11/12/2020 07:17

Dec 11 (Reuters) - Medivir AB  MVIRb.ST :
    * MEDIVIR RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY SEK
170
MILLION AND AN OVER-ALLOTMENT OPTION WITH STRONG SUPPORT FROM
EXISTING AND NEW SPECIALIST INVESTORS
    * RIGHTS ISSUE COMPRISES A MAXIMUM OF 24,276,405 CLASS B
SHARES
    * TO CARRY OUT A RIGHTS ISSUE OF CLASS B SHARES WITH
PREFERENTIAL
RIGHTS FOR EXISTING SHAREHOLDERS ( "RIGHTS ISSUE") OF
APPROXIMATELY SEK 170 MILLION BEFORE TRANSACTION COSTS
    * RIGHTS WILL PROVIDE MEDIVIR WITH PROCEEDS OF UP TO SEK 170
MILLION BEFORE TRANSACTION COSTS.
    * SUBSCRIPTION PRICE HAS BEEN SET TO SEK 7.00 PER SHARE
    * OVER-ALLOTMENT OPTION COMPRISES CLASS B SHARES AND WILL
POTENTIALLY PROVIDE MEDIVIR WITH UP TO AN ADDITIONAL SEK 25
MILLION
    * DISCOUNT OF 23 PERCENT COMPARED TO THEORETICAL EX-RIGHTS
SHARE
PRICE ("TERP"), BASED ON CLOSING PRICE FOR MEDIVIR'S SHARE ON
DECEMBER 10
    * SUBSCRIPTION PERIOD IS EXPECTED TO COMMENCE ON JANUARY 20,
2021
AND END ON FEBRUARY 3, 2021

Source text for Eikon:  ID:nWkr7YG3qB 
Further company coverage:  MVIRb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))